Literature DB >> 23676158

Public health costs for tuberculosis suspects in Wake County, North Carolina, United States.

P H Park1, D P Holland, A Wade, N D Goswami, D Bissette, J E Stout.   

Abstract

SETTING: As the incidence of tuberculosis (TB) declines in high-income countries, resources to control TB are also declining. A portion of these resources are utilized for the evaluation and treatment of persons initially suspected of, but who do not actually have, TB (TB suspects).
OBJECTIVE: To describe the cost of TB suspects to public health departments, and determine whether part of this cost can be averted using improved diagnostic tools.
DESIGN: We evaluated resource utilization for all TB suspects as well as a random sample of TB cases managed at the Wake County public health clinic during 2008-2010. The proportion of total health department costs attributable to TB suspects was estimated. A sensitivity analysis assessed the potential impact of a rapid, accurate diagnostic test to avert suspect-associated costs.
RESULTS: Of 135 patients evaluated for TB, 36 (27%) were suspects, accounting for 14% (US5,885) of the total estimated costs for managing all patients. A perfect diagnostic test with a 3-day turnaround would have averted US27,975 (53%) of the costs attributable to suspects.
CONCLUSION: A substantial proportion of public health resources is utilized to manage persons whose final diagnosis is not TB. Efficient implementation of novel rapid tests could avert substantial public health costs.

Entities:  

Mesh:

Year:  2013        PMID: 23676158     DOI: 10.5588/ijtld.12.0739

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  5 in total

1.  Impact of GeneXpert MTB/RIF assay on triage of respiratory isolation rooms for inpatients with presumed tuberculosis: a hypothetical trial.

Authors:  Lelia H Chaisson; Marguerite Roemer; David Cantu; Barbara Haller; Alexander J Millman; Adithya Cattamanchi; J Lucian Davis
Journal:  Clin Infect Dis       Date:  2014-08-04       Impact factor: 9.079

2.  Impact of GeneXpert MTB/RIF on patients and tuberculosis programs in a low-burden setting. a hypothetical trial.

Authors:  J Lucian Davis; L Masae Kawamura; Lelia H Chaisson; Jennifer Grinsdale; Jihane Benhammou; Christine Ho; Anna Babst; Houmpheng Banouvong; John Z Metcalfe; Mark Pandori; Philip C Hopewell; Adithya Cattamanchi
Journal:  Am J Respir Crit Care Med       Date:  2014-06-15       Impact factor: 21.405

3.  Cost analysis of a nucleic acid amplification test in the diagnosis of pulmonary tuberculosis at an urban hospital with a high prevalence of TB/HIV.

Authors:  Max W Adelman; Ekaterina Kurbatova; Yun F Wang; Michael K Leonard; Nancy White; Deborah A McFarland; Henry M Blumberg
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

4.  A systematic synthesis of direct costs to treat and manage tuberculosis disease applied to California, 2015.

Authors:  Peter Oh; Lisa Pascopella; Pennan M Barry; Jennifer M Flood
Journal:  BMC Res Notes       Date:  2017-08-30

5.  Rapid detection of tuberculosis in remote Alaska.

Authors:  Ronald J Bowerman
Journal:  Int J Circumpolar Health       Date:  2020-12       Impact factor: 1.228

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.